ScienceNovartis, Ionis experimental heart drug misses key trial goal

Novartis said its experimental drug pelacarsen failed in a late-stage trial to reduce the risk of major heart attacks and strokes among patients with a genetic risk factor. The result is a setback for the Swiss drugmaker's effort to revive its drug pipeline.

Novartispelacarsenclinical trialheart disease

RReuters★★☆☆☆2026-09-05 02:10Original